US FDA grants 510(k) clearance to QuidelOrtho’s VITROS hs Troponin I Assay: San Diego Tuesday, November 4, 2025, 18:00 Hrs ...
Ivonescimab combined with chemotherapy for locally advanced or metastatic NSCLC resistant to EGFR-TKI therapy, which has now been approved for marketing in China and added to China’s National ...
MedGenome invests into Gujarat-based diagnostics chain Green Cross to expand genomics offerings across India: Our Bureau, Bengaluru Tuesday, November 4, 2025, 14:15 Hrs [IST] MedG ...
Actimed Therapeutics receives Japanese patent for new composition of matter patent for S-pindolol benzoate: London, UK Tuesday, November 4, 2025, 16:00 Hrs [IST] Actimed Therapeut ...
University of Glasgow scientists use AI to study the intricate language of biomolecules: Our Bureau, Bengaluru Tuesday, November 4, 2025, 14:15 Hrs [IST] University of Glasgow sci ...
UK MHRA calls on public to report side effects and suspected fakes during #MedSafetyWeek: United Kingdom Tuesday, November 4, 2025, 15:00 Hrs [IST] The Medicines and Healthcare pr ...
Integrating family planning and maternity services reduces global maternal mortality: Geneva Tuesday, November 4, 2025, 17:00 Hrs [IST] A landmark study published in The Lancet Gl ...
Merck Foundation launches $22 million initiative to improve cardiovascular care in the US: Rahway, New Jersey Tuesday, November 4, 2025, 14:00 Hrs [IST] The Merck Foundation annou ...
Dr Reddy’s Laboratories, third largest Indian pharma major after Sun Pharmaceutical and Aurobindo Pharma, has posted net profit of Rs. 1,337 crore during the second quarter ended September 2025 ...
Roche’s phase III ALLEGORY study of Gazyva/Gazyvaro in adults with systemic lupus erythematosus meets its primary endpoint: Basel Tuesday, November 4, 2025, 12:00 Hrs [IST] Roch ...
Major change for rare disease treatments on way, signals MHRA: United Kingdom Tuesday, November 4, 2025, 13:00 Hrs [IST] The rulebook for rare disease therapies will be overhauled ...